Urology Oral Boards Practice Cases by Clinical Domain and OSCE Type
An educational domain map built from the broad areas named by ABU and the real decisions that distinguish safe urologic practice.
Key takeaways
- ABU names broad domains but does not publish a complete candidate-facing protocol blueprint; this is a SurgiTest educational practice map.
- Every domain should be practiced through diagnosis, management, operation or intervention, complication, and follow-up branches.
- OSCE practice must include communication, real-time diagnostic interpretation, and cystoscopy simulation.
- A balanced plan includes adult, pediatric, oncologic, functional, emergency, and professional scenarios rather than overlearning the candidate’s own subspecialty.
Twelve educational practice domains cover the broad clinical range named by ABU
Prostate cancer and localized or advanced disease
Risk stratification, imaging, active surveillance, surgery, radiation interfaces, nodal strategy, biochemical recurrence, advanced systemic therapy, complications, survivorship, urinary function, and sexual outcomes.
Bladder and upper-tract urothelial cancer
Hematuria evaluation, TURBT quality, risk classification, intravesical therapy, muscle-invasive disease, neoadjuvant therapy, cystectomy, urinary diversion, upper-tract disease, surveillance, and treatment complications.
Kidney, adrenal, and retroperitoneal disease
Small renal masses, locally advanced renal cancer, nephron preservation, venous tumor thrombus, adrenal lesions, retroperitoneal masses, renal functional risk, surveillance, bleeding, urine leak, and postoperative rescue.
Calculous disease and endourology
Stone evaluation, infected obstruction, decompression, metabolic assessment, medical expulsive therapy, ureteroscopy, shock-wave lithotripsy, PCNL, access, radiation safety, residual stone, ureteral injury, sepsis, and prevention.
Benign prostatic obstruction and lower urinary tract symptoms
Symptom evaluation, retention, renal consequences, medications, office testing, TURP, laser enucleation, minimally invasive therapies, simple prostatectomy, catheter strategy, bleeding, incontinence, stricture, and follow-up.
Female urology, neurourology, and urodynamics
Stress and urgency incontinence, pelvic organ prolapse, recurrent infection, fistula, neurogenic lower urinary tract dysfunction, urodynamic interpretation, upper-tract protection, medical and operative treatment, and complications.
Reconstruction, urethral disease, and genitourinary trauma
Urethral stricture, bladder neck contracture, fistula, radiation injury, ureteral injury, urethral and bladder trauma, renal trauma, genital trauma, diversion, reconstruction, tissue selection, recurrence, and functional outcomes.
Andrology, infertility, and sexual medicine
Male infertility evaluation, azoospermia, varicocele, sperm retrieval, erectile dysfunction, Peyronie disease, priapism, prosthetic surgery, endocrine and psychologic contributors, counseling, infection, erosion, and device complications.
Pediatric urology
Hydronephrosis, reflux, UPJ obstruction, posterior urethral valves, hypospadias, cryptorchidism, torsion, neurogenic bladder, urinary infection, congenital anomalies, timing, growth, renal preservation, family counseling, and long-term follow-up.
Infection, obstruction, and urologic emergencies
Urosepsis, infected obstruction, Fournier gangrene, acute retention, gross hematuria with clot retention, testicular torsion, priapism, obstructive renal failure, postoperative deterioration, antibiotic strategy, drainage, debridement, and escalation.
Transplantation, renovascular disease, and renal failure interfaces
Transplant ureteral complications, obstruction, leak, infection, hematuria, graft dysfunction, dialysis access interfaces, renal replacement planning, immunosuppression implications, reconstruction, and collaboration with transplant teams.
Imaging, pathology, office practice, ethics, and geriatric urology
CT, MRI, ultrasound, nuclear imaging, video interpretation, uropathology, cystoscopy, office procedures, anticoagulation, frailty, goals of care, capacity, consent, disclosure, professionalism, referral, quality improvement, and longitudinal follow-up.
Oncology cases should force stage, sequencing, function, and surveillance decisions
Localized prostate cancer
Risk group, life expectancy, MRI and biopsy interpretation, active surveillance versus treatment, nodal strategy, functional priorities, pathology, recurrence, and survivorship.
High-risk or recurrent prostate cancer
Staging, multimodal treatment, systemic therapy, local salvage, complications, bone and metabolic health, and longitudinal monitoring.
Non–muscle-invasive bladder cancer
TURBT quality, muscle presence, risk category, intravesical therapy, repeat resection, surveillance, treatment failure, and cystectomy threshold.
Muscle-invasive bladder cancer
Staging, neoadjuvant therapy, cystectomy candidacy, diversion selection, nodes, complications, pathology, adjuvant decisions, and surveillance.
Renal mass
Imaging, biopsy role, surveillance, ablation, partial versus radical nephrectomy, renal preservation, hereditary context, complications, and pathology.
Testicular cancer
Urgent diagnosis, orchiectomy approach, markers, staging, fertility, surveillance, chemotherapy or RPLND interfaces, and survivorship.
Benign and functional cases should still demand precise thresholds and follow-up
BPH with retention or renal consequences
Catheter and infection plan, renal assessment, medications, procedure choice, technique, bleeding, continence, and catheter removal.
Recurrent stones
Acute urgency, infection, imaging, medical or procedural selection, access, complications, stone analysis, metabolic evaluation, and prevention.
Female stress incontinence
History, examination, residual, urodynamic context, conservative care, surgery, consent, mesh or nonmesh options, retention, injury, and recurrence.
Neurogenic bladder
Risk stratification, pressures, compliance, renal protection, catheterization, medications, botulinum toxin, reconstruction, infection, and surveillance.
Urethral stricture
Etiology, imaging or endoscopy, symptoms, renal or infection consequences, dilation versus urethroplasty, graft strategy, recurrence, and function.
Erectile dysfunction or infertility
Etiology, hormonal and psychologic context, medical and surgical options, fertility goals, counseling, prosthetic or retrieval technique, and complications.
Emergency cases should be practiced as time-to-action problems
| Opening scenario | Immediate decision | Complication branch |
|---|---|---|
| Fever, flank pain, hypotension, obstructing stone | Resuscitation, antibiotics, and urgent drainage | Persistent shock, failed retrograde access, abscess, renal failure. |
| Sudden testicular pain | Clinical torsion decision and urgent exploration | Nonviable testis, delayed presentation, contralateral findings, fertility counseling. |
| Gross hematuria and retention | Large-bore drainage, irrigation, hemodynamic and anticoagulation assessment | Ongoing bleeding, perforation, inability to clear clot, transfusion or embolization. |
| Perineal pain, crepitus, sepsis | Fournier resuscitation, antibiotics, and immediate debridement | Repeat debridement, critical illness, diversion, reconstruction. |
| Pelvic trauma with blood at meatus | Avoid blind catheterization and coordinate trauma evaluation | Bladder injury, associated hemorrhage, delayed stricture, reconstruction. |
| Postoperative hypotension and oliguria | Reopen bleeding, leak, obstruction, sepsis, renal, cardiac, and pulmonary diagnoses | Return to OR, drainage, embolization, ICU, renal replacement. |
Pediatric and transplant cases test longitudinal organ protection and collaboration
Prenatal hydronephrosis or UPJ obstruction
Postnatal evaluation, infection prevention, function, timing, operation, stent, growth, and follow-up.
Posterior urethral valves
Neonatal stabilization, drainage, renal and bladder assessment, ablation, persistent dysfunction, transplantation risk, and lifelong surveillance.
Cryptorchidism or hypospadias
Timing, anatomy, fertility and malignancy implications, surgical plan, complications, and family counseling.
Transplant ureteral leak or obstruction
Graft function, imaging, drainage, nephrostomy or stent, infection, reconstruction, and coordination with the transplant team.
Hematuria or mass in a transplant recipient
Immunosuppression, infection, malignancy, graft and native-tract evaluation, biopsy or intervention, and multidisciplinary sequencing.
Run a dedicated OSCE circuit every week
| OSCE type | Practice scenario | Observable endpoint |
|---|---|---|
| Professionalism and communication | Disclose a ureteral injury, counsel a patient declining cancer treatment, discuss infertility, manage conflict, or obtain high-risk consent | Purpose, empathy, plain language, recommendation, options, understanding, documentation, and follow-up. |
| Diagnostic or real-time intervention | Interpret CT urogram, renal mass MRI, urodynamics, ultrasound, fluoroscopy, pathology, or endoscopic video | Orientation, decisive finding, diagnosis, urgency, action, and verification. |
| Cystoscopy simulation | Evaluate hematuria, obstruction, stricture, tumor, stone, foreign body, or catheter difficulty | Safe setup, atraumatic entry, systematic landmarks, findings, intervention, complications, and aftercare. |
A complete practice case contains five layers
- 01
Opening decision
What is the immediate threat, diagnosis, or next test?
- 02
Management commitment
What do you recommend, why, and what alternative is reasonable?
- 03
Technical or communication task
Describe an operation, interpret a study, perform a procedural sequence, or counsel a patient.
- 04
Changed condition
Complication, pathology, new imaging, renal deterioration, patient preference, or resource limitation.
- 05
Outcome and follow-up
Surveillance, function, prevention, disclosure, rehabilitation, recurrence, and ownership.
Put the framework under pressure
Practice the answer out loud—not only on paper.
Voice-first cases, adaptive examiner follow-up, imaging, complications, and structured educational feedback for urology.
Questions candidates ask
Frequently asked questions
What is the current ABU Certifying Examination format?
The current ABU examination webpage describes two 45-minute encounters with different examiner teams, composed of three standardized oral protocols and three OSCEs. The ABU’s current official overview further describes three eight-item protocols completed in one 45-minute session and three OSCEs lasting about 10–13 minutes each in a second session.
Does the Urology Certifying Examination use personal cases?
The ABU evaluates clinical practice before admission through practice-log review, complication narratives, peer review, and credentialing. The oral examination itself uses Board-developed standardized protocols and OSCEs rather than candidate-selected oral cases. de-identified personal-case exercises are therefore an educational way to rehearse de-identified real-practice decisions and complications, not a substitute for the ABU log or a claim that those cases will be examined orally.
What is required for the 2027 ABU practice log?
The current 2027 electronic instructions require one physician-selected six-consecutive-month period of 160–180 days between April 1, 2025 and August 31, 2026, using the same period across all applicable practice locations. The log includes all office visits, procedures, and other billed patient services and is due September 1, with a late window through September 15.
How does ABU describe scoring?
ABU materials describe point scoring for sections within each protocol plus an overall assessment, with standardized answers and adjustment for examiner, question, and protocol difficulty. The 2026 ABU Report identifies diagnosis, management, follow-up, and overall ability as scored clinical-skill categories and describes a multifaceted Rasch and Fair Average approach. ABU does not publish a candidate-facing cut-score formula for SurgiTest to reproduce.
Does SurgiTest reproduce ABU examination questions or predict certification?
No. SurgiTest uses original educational scenarios based on public exam structure and general clinical practice. It does not solicit or reproduce secure examination content, calculate an official ABU score, predict certification, guarantee a result, or claim endorsement by the American Board of Urology.
Source transparency
Official references
Board requirements, dates, and candidate instructions can change. Confirm current details directly with ABU and the Board’s candidate portal.
Continue preparing